Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer

Clinical trial NCT07067255 · RECRUITING

Trial details

NCT number: NCT07067255
Sponsor: Essen Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Ovarian Carcinoma Ovarian Sarcoma Ovarian Cancer Stage IV

Start date: 2025-04-29
Primary completion: 2028-12-10
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.